When Cancer Gets Personal: How Biomarkers Enrich the World of Precision Medicine

By advancing our understanding of cancer pathophysiology and tumor profiling, they play a critical role in the rational development of novel therapies.

Despite their many potential advantages, biomarker development and biomarker-guided trials can be complex and costly. With thorough planning and clarity around the overall objective, however, these trials promise to deliver better outcomes for patients in need of life-changing therapies.

Webinar topics will include:

  • The evolution of biomarker-guided oncology trials
  • Driving smarter study design: Enhancing efficacy through biomarker-matched trials
  • Data considerations and limitations: The impact of next-generation sequencing, access to data, and challenges with global trial execution
  • What’s next for precision oncology and where biomarkers are heading

Request Free!